Photo of Ruben Mesa from thepatientstory.com
Sep 16, 2023, 18:02
Ruben A. Mesa: Deeply excited by the Food and Drug Administration approval of Momelotinib for patients with myelofibrosis with anemia.
Quoting Ruben A. Mesa, the President of Atrium Health Levine Cancer, on X/Twitter:
“Deeply excited by the FDA approval of Momelotinib for patients with myelofibrosis with anemia, grateful for all selfless participation of patients and MPN colleagues that led to this advance.”
For details click here.
Source: Ruben A. Mesa/Twitter
Aug 13, 2024, 01:52